Home » Topics » BioWorld Science

BioWorld Science
RSS

Dolastatin 10 mimic dolaphenine androstane

Sep. 13, 1996

Antitumor agents from Samjin

Sep. 13, 1996

Phase I trial of a new antiangiogenic agent from Daiichi

Sep. 13, 1996

Antiangiogenic eponemycin analogues

Sep. 13, 1996

IL-2 receptor-binding polypeptide described by Boehringer Ingelheim

Sep. 13, 1996

The Liposome Company prepares and formulates new taxanes

Sep. 13, 1996

Improved camptothecin derivatives

Sep. 13, 1996

BioTransplant licenses bone marrow processing device for use in organ transplantation

Sep. 13, 1996

Generic ciclosporin progressing ahead of schedule

Sep. 13, 1996

Progress in arthritis at Toyama

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...